National drug safety program stalls in India; Counterfeiter re-sentenced, sent back to jail;

> Red tape has stalled the national pharmacovigilance program in India. Article

> A Chinese national has been re-sentenced to prison for misbranding and conspiring to distribute counterfeit drugs. Article

> Generic injectables maker Hospira has acquired the like-focused business of Orchid Chemicals & Pharmaceuticals. Release

> Owens & Minor now offers cGMP-compliant, third-party logistics and business-process outsourcing services to life sciences manufacturers. Release

> Through an agreement with Target Corp, Par Logistics Management offers a system to monitor and control reefer temperatures, react and respond to temperature alarms, and optimize logistics and management of cold chain assets. Announcement

Suggested Articles

Teva will produce its new migraine drug at a plant in Israel and more news of note.

The shortage of childhood cancer drug vincristine was front and center during the Senate hearing for Stephen Hahn, nominee for FDA commissioner.

The FDA has lambasted the Torrent Pharmaceuticals in a warning letter for making OTC meds using water tainted with bacteria.